FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1569304607> ?p ?o ?g. }

• W1569304607 endingPage "756" @default.
• W1569304607 startingPage "749" @default.
• W1569304607 abstract "The prognosis of patients diagnosed with glioblastoma remains dismal in spite of the current concomitant chemoradiotherapy with temozolomide. In particular, the resistance to temozolomide appears to be the greatest obstacle to the treatment of glioblastoma. In the present study, we evaluated in vitro and in vivo the antitumor effects of combination therapy of cilengitide with belotecan, a camptothecin derivate, to treat experimental glioblastoma. The therapeutic effects of the drugs on the U87MG and U251MG human glioblastoma cell lines were assessed using in vitro cell viability and apoptosis assays. The combination treatment group with cilengitide and belotecan enhanced the cytotoxic effects to the glioblastoma cell lines and increased the apoptosis of the tumor cells compared to monotherapy with either drug alone in vitro. Nude mice with established U87MG glioblastoma were assigned to the following four groups: control, cilengitide, belotecan and combination treatment. The volume of tumors and length of survival were also measured. Animals in the combination therapy group demonstrated a significant reduction of tumor volume and an increase in survival (p < 0.05). Immunohistochemistry revealed a decrease in angiogenesis by cilengitide and an increase in apoptosis by cilengitide and belotecan in vivo. The combination therapy of cilengitide with belotecan presented more cytotoxic effects compared to the monotherapy of either drug in vitro and in vivo. This combination protocol may serve as an alternative treatment option for glioblastoma." @default.
• W1569304607 created "2016-06-24" @default.
• W1569304607 creator A5000179774 @default.
• W1569304607 creator A5014037323 @default.
• W1569304607 creator A5017943773 @default.
• W1569304607 creator A5022869761 @default.
• W1569304607 creator A5033093147 @default.
• W1569304607 creator A5037531553 @default.
• W1569304607 creator A5053617939 @default.
• W1569304607 creator A5069506752 @default.
• W1569304607 creator A5089418123 @default.
• W1569304607 date "2013-02-27" @default.
• W1569304607 modified "2023-10-18" @default.
• W1569304607 title "Combination therapy of cilengitide with belotecan against experimental glioblastoma" @default.
• W1569304607 cites W1970233014 @default.
• W1569304607 cites W1976520103 @default.
• W1569304607 cites W2002295366 @default.
• W1569304607 cites W2025811635 @default.
• W1569304607 cites W2027053077 @default.
• W1569304607 cites W2032499139 @default.
• W1569304607 cites W2037150903 @default.
• W1569304607 cites W2080208032 @default.
• W1569304607 cites W2092228141 @default.
• W1569304607 cites W2096287682 @default.
• W1569304607 cites W2101013262 @default.
• W1569304607 cites W2101659090 @default.
• W1569304607 cites W2115516828 @default.
• W1569304607 cites W2116620076 @default.
• W1569304607 cites W2121417576 @default.
• W1569304607 cites W2130527861 @default.
• W1569304607 cites W2130941606 @default.
• W1569304607 cites W2132607958 @default.
• W1569304607 cites W2132697290 @default.
• W1569304607 cites W2139304914 @default.
• W1569304607 cites W2145781637 @default.
• W1569304607 cites W2150456585 @default.
• W1569304607 cites W2160826199 @default.
• W1569304607 doi "https://doi.org/10.1002/ijc.28058" @default.
• W1569304607 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23354807" @default.
• W1569304607 hasPublicationYear "2013" @default.
• W1569304607 type Work @default.
• W1569304607 sameAs 1569304607 @default.
• W1569304607 citedByCount "21" @default.
• W1569304607 countsByYear W15693046072014 @default.
• W1569304607 countsByYear W15693046072015 @default.
• W1569304607 countsByYear W15693046072016 @default.
• W1569304607 countsByYear W15693046072017 @default.
• W1569304607 countsByYear W15693046072018 @default.
• W1569304607 countsByYear W15693046072019 @default.
• W1569304607 countsByYear W15693046072020 @default.
• W1569304607 countsByYear W15693046072021 @default.
• W1569304607 countsByYear W15693046072022 @default.
• W1569304607 countsByYear W15693046072023 @default.
• W1569304607 crossrefType "journal-article" @default.
• W1569304607 hasAuthorship W1569304607A5000179774 @default.
• W1569304607 hasAuthorship W1569304607A5014037323 @default.
• W1569304607 hasAuthorship W1569304607A5017943773 @default.
• W1569304607 hasAuthorship W1569304607A5022869761 @default.
• W1569304607 hasAuthorship W1569304607A5033093147 @default.
• W1569304607 hasAuthorship W1569304607A5037531553 @default.
• W1569304607 hasAuthorship W1569304607A5053617939 @default.
• W1569304607 hasAuthorship W1569304607A5069506752 @default.
• W1569304607 hasAuthorship W1569304607A5089418123 @default.
• W1569304607 hasBestOaLocation W15693046071 @default.
• W1569304607 hasConcept C126322002 @default.
• W1569304607 hasConcept C143998085 @default.
• W1569304607 hasConcept C150903083 @default.
• W1569304607 hasConcept C154317977 @default.
• W1569304607 hasConcept C190283241 @default.
• W1569304607 hasConcept C202751555 @default.
• W1569304607 hasConcept C207001950 @default.
• W1569304607 hasConcept C2776999253 @default.
• W1569304607 hasConcept C2777389519 @default.
• W1569304607 hasConcept C2778227246 @default.
• W1569304607 hasConcept C2780394083 @default.
• W1569304607 hasConcept C502942594 @default.
• W1569304607 hasConcept C55493867 @default.
• W1569304607 hasConcept C71924100 @default.
• W1569304607 hasConcept C86803240 @default.
• W1569304607 hasConcept C98274493 @default.
• W1569304607 hasConceptScore W1569304607C126322002 @default.
• W1569304607 hasConceptScore W1569304607C143998085 @default.
• W1569304607 hasConceptScore W1569304607C150903083 @default.
• W1569304607 hasConceptScore W1569304607C154317977 @default.
• W1569304607 hasConceptScore W1569304607C190283241 @default.
• W1569304607 hasConceptScore W1569304607C202751555 @default.
• W1569304607 hasConceptScore W1569304607C207001950 @default.
• W1569304607 hasConceptScore W1569304607C2776999253 @default.
• W1569304607 hasConceptScore W1569304607C2777389519 @default.
• W1569304607 hasConceptScore W1569304607C2778227246 @default.
• W1569304607 hasConceptScore W1569304607C2780394083 @default.
• W1569304607 hasConceptScore W1569304607C502942594 @default.
• W1569304607 hasConceptScore W1569304607C55493867 @default.
• W1569304607 hasConceptScore W1569304607C71924100 @default.
• W1569304607 hasConceptScore W1569304607C86803240 @default.
• W1569304607 hasConceptScore W1569304607C98274493 @default.
• W1569304607 hasIssue "3" @default.
• W1569304607 hasLocation W15693046071 @default.

• next